NCT05292664 2026-03-12Venetoclax Basket Trial for High Risk Hematologic MalignanciesDana-Farber Cancer InstitutePhase 1 Recruiting30 enrolled
NCT04988555 2025-04-02A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 MutationSumitomo Pharma America, Inc.Phase 1/2 Recruiting362 enrolled
NCT05476770 2024-12-06Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesTherapeutic Advances in Childhood Leukemia ConsortiumPhase 1 Recruiting54 enrolled